Yes and HER-Vaxx demonstrated very good efficacy after the completion of Ph2 clinical trial for HER-Vaxx. But like I said, PH doesn't want to sell it for $100M and use that to fund the development of the other IP, he would prefer to do CR to bring all the IP to a development stage to attract BP to buy the entire company to maximise the IP worth. And the big IP are CF33 and Azer-Cel.
IMU Price at posting:
3.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)